Cancer research is laced throughout all of Virginia Tech Carilion Research Institute’s focus areas. It is a formidable challenge. Cancer cells grow uncontrollably, and they evade even the most aggressive treatments. Researchers at the VTCRI are beginning to understand the molecular mechanisms underlying the genetic and environmental factors that encourage cancer growth, as well as how cancer multiplies and migrates throughout the body. With this new knowledge, researchers are developing methods to make cancer cells more vulnerable to existing treatments, as well as innovating completely new treatments in efforts to stop cancer and prevent it from recurring.

Recent News

Bhanu Tewari and Harald Sontheimer

Nov. 6, 2018

Scientists solve century-old neuroscience mystery; answers may lead to epilepsy treatment

Scientists at the Virginia Tech Carilion Research Institute have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for ...

Glioblastoma cells

Sept. 11, 2018

VTCRI research team identifies a potential strategy in fight against brain cancer

Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s sleep cycle is a potential target for therapies to help ...

Deb Kelly, Ph.D.

July 11, 2018

VTCRI scientist earns third concurrent grant from the National Cancer Institute to study breast cancer

Deb Kelly, an associate professor at the Virginia Tech Carilion Research Institute, was awarded $2.1 million by the National Cancer Institute (NCI) to study the ...

More news >>